exaprolol has been researched along with Coronary Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hughes, B; Kane, KA; McDonald, FM; Parratt, JR | 1 |
| Barta, E; Dzurba, A; Okolicány, J; Styk, J; Ziegelhöffer, A | 1 |
3 other study(ies) available for exaprolol and Coronary Disease
| Article | Year |
|---|---|
Aspects of the cardiovascular pharmacology of exaprolol.
Topics: Action Potentials; Adrenergic beta-Antagonists; Anesthesia; Animals; Arrhythmias, Cardiac; Cats; Coronary Disease; Coronary Vessels; Female; Guinea Pigs; Hemodynamics; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Papillary Muscles; Propanolamines; Purkinje Fibers; Rats; Rats, Inbred Strains; Sheep; Species Specificity | 1984 |
The influence of exaprolol upon the ischaemic rat heart and its interaction with sarcolemmal (Na+ + K+)-ATPase.
Topics: Adrenergic beta-Antagonists; Animals; Blood Flow Velocity; Blood Pressure; Cardiac Output; Coronary Disease; Heart; Male; Propanolamines; Rats; Rats, Inbred Strains; Sarcolemma; Sodium-Potassium-Exchanging ATPase; Stroke Volume | 1989 |
[Cardioprotective and membrane effects of exaprolol].
Topics: Adenosine Triphosphatases; Adrenergic beta-Antagonists; Animals; Coronary Disease; Heart; In Vitro Techniques; Male; Propanolamines; Rats; Sarcolemma | 1986 |